Toxicological safety assessment of iomeprol, a new X-ray contrast agent.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European Journal of Radiology

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0720-048X(94)90091-4PMID 8020516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of organic osmolytes in adaptation of renal cells to high osmolality

  2005cited by this paper
• Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.

  1994cited by this paper
• Pharmacokinetics and tissue distribution of iomeprol in animals.

  1994cited by this paper
• The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.

  1994cited by this paper
• Toxicity in animals and safety in humans: the predictive value of animal studies.

  1992cited by this paper
• Serious or fatal complications after inadvertent administration of ionic water-soluble contrast media in myelography.

  1992cited by this paper
• Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys.

  1991cited by this paper
• Muscle Toxicity of Diatrizoate and Iohexol in Rabbits

  1991cited by this paper
• New aspects of osmotic pressure, flow, load, and bolus in adverse reactions and toxicity of contrast media.

  1991cited by this paper
• New Aspects of Osmotic Pressure, Flow, Load, and Bolus in Adverse Reactions and Toxicity of Contrast Media

  1991cited by this paper
• The Adverse Effects of Angiographic Radiocontrast Media

  1991cited by this paper
• Immunologic basis for adverse reactions to radiographic contrast media.

  1990cited by this paper
• Intracellular penetration and accumulation of radiographic contrast media in the rat kidney.

  1990cited by this paper
• Acute and Subacute Toxicity Studies of Ioversol in Experimental Animals

  1989cited by this paper
• Summary of the toxicologic profile of iopentol.

  1987cited by this paper
• The pharmacology of intravascular radiocontrast media.

  1986cited by this paper
• Light- and electron-microscopic evaluation of renal tubular cell vacuolation induced by administration of nitrilotriacetate or sucrose.

  1985cited by this paper
• Manual of Pharmacologic Calculations: With Computer Programs

  1984cited by this paper
• Contrast media reactions: experimental evidence against the allergy theory.

  1984cited by this paper
• Endocytosis of enveloped animal viruses.

  1982cited by this paper
• Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.

  1982cited by this paper
• Contrast media adverse reactions: occurrence, recurrence, and distribution patterns.

  1982cited by this paper
• Drug approval and licensing procedures in Japan 1981

  1981cited by this paper
• Osmolality of intravascular radiological contrast media.

  1980cited by this paper
• Contrast media reactions: data analysis and hypothesis.

  1980cited by this paper
• IgE-mediated adverse reactivity to a radiographic contrast medium.

  1976cited by this paper
• The allergic theory of radiocontrast agent toxicity: demonstration of antibody activity in sera of patients suffering major radiocontrast agent reactions.

  1976cited by this paper
• Unusual local reaction to iodinated contrast medium.

  1975cited by this paper
• Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man. A Retrospective Study of 47 Cases.

  1975cited by this paper
• Acute renal failure after intravenous urography: detection of antibodies against contrast media.

  1974cited by this paper
• Overdose at excretory urography: toxic cause of death.

  1972cited by this paper
• Fatal overdose of contrast medium in infants.

  1970cited by this paper
• Comparison of the cardiac effects of vagus nerve stimulation and of acetylcholine infusions.

  1969cited by this paper
• Acute effects of increased serum osmolality on left ventricular performance.

  1969cited by this paper
• Basic mechanisms of contrast media reactions. Theoretical and experimental considerations.

  1968cited by this paper
• Hemodynamic reactions to angiographic media. A survey and commentary.

  1968cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Venous Thromboembolism Management in Pregnant Patients.

  2023cites this paper
• Acute Ischemic Stroke in Pregnancy

  2022cites this paper
• Contrast Agents in Pregnancy and Breastfeeding

  2021cites this paper
• Ischemic stroke during pregnancy and puerperium

  2021cites this paper
• Pregnancy and Colorectal Cancer, from Diagnosis to Therapeutical Management - Short Review.

  2020cites this paper
• Emergency Imaging of Pregnant Patients

  2020cites this paper
• Colorectal Cancer in Pregnant Woman

  2020cites this paper
• Imaging of Neurological Emergencies During Pregnancy and the Puerperium

  2020cites this paper
• Pancreatic Neuroendocrine Tumour in Pregnancy - Diagnosis and Treatment Management.

  2019cites this paper
• Contribution of Italian Clinical Research for Contrast Media-Induced Nonrenal Adverse Drug Reactions over the Last Three Decades: A Systematic Review

  2018cites this paper
• Safety of Contrast Material Use During Pregnancy and Lactation.

  2017cites this paper
• Changes in mutagenicity and acute toxicity of solutions of iodinated X-ray contrast media during chlorination.

  2015cites this paper
• Contrast Media for X-ray and Magnetic Resonance Imaging: Development, Current Status and Future Perspectives

  2015cites this paper
• Pregnancy and Lactation: Intravascular Use of Contrast Media

  2014cites this paper
• Special Theme Topic : Stroke During Pregnancy or Delivery Endovascular Treatment in Pregnancy

  2013cites this paper
• Röntgen-, MR- oder Ultraschallkontrastmittel während der Schwangerschaft oder Stillzeit: Was ist zu beachten?

  2012cites this paper
• Neuroimaging during Pregnancy

  2011cites this paper
• Author's personal copy Toxicological relevance of emerging contaminants for drinking water quality

  2010cites this paper
• Toxicological relevance of emerging contaminants for drinking water quality.

  2010cites this paper
• Pregnancy and Lactation

  2009cites this paper
• ESTUDIOS DE RADIODIAGNÓSTICO DURANTE EL EMBARAZO

  2009cites this paper
• Injections de produits iodés : les complications, les préventions possibles

  2008cites this paper
• Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.

  2008cites this paper
• Contrast Considerations in Pregnancy

  2008cites this paper
• Guidelines for Computed Tomography and Magnetic Resonance Imaging Use During Pregnancy and Lactation

  2008cites this paper
• Effects of iodinated contrast media on endothelium: An in vitro study.

  2007cites this paper
• Indikationen und Kontraindikationen kontrastmittelverstärkter MRT- und CT-Untersuchungen in der Schwangerschaft

  2007cites this paper
• Stroke in Pregnancy

  2007cites this paper
• Imaging diagnosis of acute pulmonary embolism

  2007cites this paper
• Neurological disorders in pregnancy from a neuroimaging perspective.

  2007cites this paper
• [Indications and contraindications for contrast-enhanced MRI and CT during pregnancy].

  2007cites this paper
• Neurological Disorders in Pregnancy from a Neuroimaging Perspective

  2007cites this paper
• CT pulmonary angiography versus ventilation-perfusion scintigraphy in pregnancy: implications from a UK survey of doctors' knowledge of radiation exposure.

  2006cites this paper
• Preclinical safety assessment of contrast media: predictive value

  2006cites this paper
• Iodinated and Gadolinium Contrast Media During Pregnancy and Lactation

  2006cites this paper
• Diagnosis of suspected venous thromboembolic disease in pregnancy.

  2006cites this paper
• The use of iodinated and gadolinium contrast media during pregnancy and lactation

  2005cites this paper
• Contrast media: physiocochemic properties, physiologic effects and selection

  2005cites this paper
• Effects of hyperosmolar ionic and low osmolar non-ionic contrast media on coagulation times and some blood parameters in dogs: an in vivo study.

  2003cites this paper
• Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas.

  2003cites this paper
• Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT.

  2002cites this paper
• Iomeprol: Current and Future Profile of a Radiocontrast Agent

  2001cites this paper
• Preclinical Profile of the Monodisperse Iodinated Macromolecular Blood Pool Agent P743

  2001cites this paper
• Clinical Experience with Iomeprol in Myelography and Myelo-CT: Clinical Pharmacology and Double-Blind Comparisons with Iopamidol, Iohexol, and Iotrolan

  2001cites this paper
• Iomeprol

  2000cites this paper
• Transplacental passage of iohexol.

  2000cites this paper
• Adverse Reactions to Iodinated Radiographic Contrast Media

  1999cites this paper
• A Microangiographic Technique Using Synchrotron Radiation to Visualize Dermal Circulation in Vivo

  1998cites this paper
• Comparative toxic effects of iobitridol and iohexol on the kidney.

  1998cites this paper
• Diagnostic imaging modalities during pregnancy.

  1998cites this paper
• Iodinated contrast material in uroradiology. Choice of agent and management of complications.

  1997cites this paper
• Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium.

  1996cites this paper
• Competitive development of new ultrasound, X-ray and MR contrast media.

  1996cites this paper
• [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to cynomolgus monkeys by repeated intravenous administration for 4 weeks with a 4-week recovery period].

  1995cites this paper
• A randomized, double-blind, parallel group trial of iomeprol, iohexol and iopamidol in intravenous urography.

  1995cites this paper
• [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].

  1995cites this paper
• [Intravenous single dose toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, in mice, rats and monkeys].

  1995cites this paper
• Preclinical Pharmacokinetics and General Toxicology of Iodixanol

  1995cites this paper
• Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.

  1994cites this paper
• A randomised, double-blind trial of iomeprol and iopromide in intravenous excretory urography.

  1994cites this paper
• Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.

  1994cites this paper
• Clinical utility and safety profile of iomeprol.

  1994cites this paper
• A randomised, double-blind trial of iomeprol and intravenous excretory urography

  1994cites this paper
• Clinical pharmacology of iomeprol.

  1994cites this paper
• The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.

  1994cites this paper
• Pharmacokinetics and tissue distribution of iomeprol in animals.

  1994cites this paper
• Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.

  1994cites this paper
• Pharmacodynamic effects of iomeprol for injection in experimental animals.

  1994cites this paper